Evidence map›Paper›PMID 37821097›Full record

ArticleCancer reports (Hoboken, N.J.)2023

The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma.

Basil H Chaballout, Eric M Chang, Narek Shaverdian, Percy P Lee, Phillip J Beron, Michael L Steinberg, Ann C Raldow

Open access · goldAbstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Improving our understanding of the quality of life of patients with metastatic or recurrent/persistent anal cancer: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  2. Article
  3. Patients' perspective in anal cancer.ESMO gastrointestinal oncology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Basil H ChaballoutSchool of Medicine Greenville, University of South Carolina, Greenville, South Carolina, USA.ORCID 0000-0002-4481-7958
Eric M ChangSchool of Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Narek ShaverdianMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-0294-8749
Percy P LeeCancer Treatment Centers of America, Cancer Treatment Centers of America, Phoenix, Arizona, USA.
Phillip J BeronCancer Treatment Centers of America, Cancer Treatment Centers of America, Phoenix, Arizona, USA.
Michael L SteinbergCancer Treatment Centers of America, Cancer Treatment Centers of America, Phoenix, Arizona, USA.
Ann C RaldowCancer Treatment Centers of America, Cancer Treatment Centers of America, Phoenix, Arizona, USA.ORCID 0000-0001-8996-6810
Cancer Treatment Centers of America · USMemorial Sloan Kettering Cancer Center · USOregon Health & Science University · USUniversity of South Carolina · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundLittle is known regarding anal cancer patients' perspectives on undergoing radiation therapy. Additionally, the stigma surrounding anal cancer diagnosis warrants a better understanding of the barriers to complete disclosure in patient-healthcare team interactions.

methodsIncluded patients had squamous cell carcinoma of the anus treated with definitive chemoradiation (CRT) from 2009 to 2018. Survey questions were adapted from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and Discrimination and Stigma Scale.

resultsA total of 46 anal cancer patients who underwent CRT were surveyed, of which 72% responded. 73% of respondents indicated little to no pre-treatment knowledge of CRT. 70% reported overall short-term effects as worse than expected, most commonly with bowel habits (82%), energy (73%), and interest in sexual activity (64%). 39% reported overall long-term effects to be worse than expected, most commonly with changes to bowel habits (73%), sexual function (67%), and interest in sexual activity (58%). However, 94% agreed they were better off after treatment. Regarding stigma, a subset reported hiding their diagnosis (12%, 24%) and side effects (24%, 30%) from friends/family or work colleagues, respectively, and 15% indicating they stopped having close relationships due to concerns over stigma.

conclusionsAlthough patients' perceptions of the severity of short-term CRT side effects were worse than expectations, the vast majority agreed they were better off after treatment. Targeted counseling on common concerns may improve the anal cancer treatment experience. A notable subset reported stigma associated with treatment, warranting further evaluation to understand the impact on the patient experience.

Indexed as

Anus NeoplasmsMotivationChemoradiotherapyHumansQuality of LifeTreatment Outcomeanal cancerpatient expectationpatient perspectiveradiation oncologystigma

Identifiers

PMID37821097
PMCPMC10728539
OpenAlexW4387520797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.